Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
KORIO logo — Clinical Trial RTSM Software. Ready for the Trials Ahead™

KORIO

Clinical Trial RTSM Software. Ready for the Trials Ahead™

Founded 2021 United States United States 27 employees Venture round Total: $6.80M

General Information

Company Name KORIO
Founded Year 2021
Location United States United States
Employees 27
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with KORIO. To contact KORIO, visit korioclinical.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About KORIO

KORIO is a Randomization & Trial Supply Management (RTSM) platform which prides itself on being Ready for the Trials Ahead™. The platform is designed to offer flexibility, quality, and speed, with a focus not just on tackling clinical trial challenges as they arise, but on preventing them in the first place. Founded in 2021 and headquartered in the United States, KORIO recently secured a significant $6.80M Venture Round investment on 10 October 2023. The investment was made by Boston Millenia Partners and Excelerate Health Ventures. This injection of funding is expected to bolster KORIO's capabilities and enhance its position within the industry.

Taxonomy: RTSM platform, compliance-centric, clinical trials, regulatory, audit-readiness, GxP compliant

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $6.80M 2
Boston Millenia Partners Excelerate Health Ventures
Boston Millenia Partners, Excelerate Health Ventures
10 Oct 2023

KORIO Alternatives & Competitors

View All Alternatives
KORIO vs
Clinipace
Clinipace United States

At Clinipace, It's Personal

Series C
315 employees
Biotechnology
KORIO vs
Avania
Avania United States

The Only Global CRO Built for MedTech

Private Equity
381 employees
Health Care, Medical Devices
KORIO vs
Ageless Zen, Inc.
Ageless Zen, Inc. United States

Science In Balance With Nature®

8 employees
Health Care, Wellness Beauty
View all alternatives

FAQ About KORIO

Clinical Trial RTSM Software. Ready for the Trials Ahead™
KORIO was founded in 2021.
KORIO is headquartered in United States.
KORIO has approximately 27 employees.
KORIO has completed 1 funding round, raising a total of $6.80M. The latest funding stage is Venture round.
Top alternatives and competitors to KORIO include Clinipace, Avania, Ageless Zen, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
KORIO and Clinipace are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for KORIO, https://bouncewatch.com/company/korio-inc, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes